Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations with a high degree of accuracy.

Dupilumab significantly reduced the risk of exacerbations compared with placebo in children with moderate to severe asthma, regardless of exacerbation history. Dupilumab was shown to consistently ...

Depemokimab significantly reduces asthma exacerbations, showing similar efficacy in both controlled and uncontrolled asthma patients. The study included patients with eosinophilic asthma using medium- ...

Please provide your email address to receive an email when new articles are posted on . Odds for exacerbation-prone classification increased 40% with each 20-point decrease in Child Opportunity Index ...

Conceptual of sickness woman feeling when admitted in the hospital. CHRONICLE trial findings offer a glimpse of the real-world outcomes of patients using benralizumab for severe asthma over a years’ ...

In a recent study published in the Journal of Investigational Allergology and Clinical Immunology, researchers reviewed the genomics, transcriptomics, and epigenetics of asthma exacerbations (AEs).

—Researchers from Australia conducted a year-round study to investigate the impacts of different pollen types on asthma exacerbations in both children and adults. Population studies in children and ...

Only 15% of patients were adherent to ICS therapy 3 months after their asthma exacerbation, and less that one-fourth of those remained adherent 9 months later. Improved adherence to inhaled ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a lower risk for acute asthma exacerbations in ...